摘要
目的观察鼻腔、韦氏环NK/T细胞淋巴瘤放化疗疗效,并分析影响预后的因素。方法2000--2010年本院共收治经免疫组化确诊130例鼻腔、韦氏环NK/T细胞淋巴瘤,其中鼻腔的109例、韦氏环的21例。AnnArbor分期IE期116例、ⅡE期14例。单纯放疗30例,单纯化疗2例,放化疗联合98例。结果随访率100%,随访时间满5年者78例。完全缓解率全组为89.2%,IE、ⅡF期的分别为88.8%、92.9%(X2=0.02,P=0.837),单纯放疗、放化疗联合的分别为86%、96%(X2=1.44,P=0.230)。全组5年总生存(OS)和无瘤生存(DFS)率分别为58.0%和57.2%,IE、ⅡE期患者5年OS分别为60.6%、36.3%(X2=0.25,P:0.615),5年DFS分别为59.7%、36.3%(X2=0.21,P=0.648);单纯放疗、放化联合的5年OS分别为70%、48%(X2=0.01,P=0.933),5年DFS分别为66%和48%(X2=0.09,P=0.764)。单纯放疗、放化联合的主要3、4级不良反应总发生率分别为6.7%、54.1%(x。=41.38,P=0.002)。原发灶照射剂量(X2=3.18,P=0.005)、ECOG评分(X2=2.97,P=0.008)与OS相关。结论IE、ⅡE期鼻腔、韦氏环NK/T细胞淋巴瘤放化联合与单纯放疗疗效相似,但不良反应较重;原发灶照射剂量、ECOG评分是影响OS的因素。
Objective To observe the clinical effects of radiotherapy and/or chemotherapy in the treatment of nasal and Waldeyer ring natural killer ( NK)/T cell lymphoma and to analyze the prognostic factors. Methods Between January 20, 2000 and December 21, 2010, 109 patients with nasal NK/T cell lymphoma and 21 patients with Waldeyer ring NK/T cell lymphoma were admitted to our hospital; the diagnosis was confirmed by immunohistochemistry. According to the Ann Arbor staging system, 116 patients were classified as stage I E, and 14 as stage IIE. Thirty patients received radiotherapy alone;2 patients received chemotherapy alone; 98 patients received radiochemotherapy. Results The follow-up rate was 100%. Seventy-eight patients were followed up for at least 5 years. The complete remission (CR) rate was 89. 2% in all patients. The CR rates of stage I E patients and stage IIE patients were 88.8% and 92. 9%, respectively ( X2 = 0. 02, P = 0. 837 ). The CR rates of patients receiving radiotherapy alone and patients receiving radiochemotherapy were 86% and 96%, respectively (X2 = 1.44, P = 0. 230). The five-year overall survival (OS) rate and disease-free survival (DFS) rate of all patients were 58. 0% and 57.2% , respectively. The five-year OS rates of stage I E patients and stage IIE patients were 60. 6% and 36. 3%, respectively (X2 = 0. 25, P = 0. 615) ;the five-year DFS rates of stage I E patients and stage II E patients were 59.7% and 36. 3%, respectively ( X2 = 0. 21, P = 0. 648 ). The five-year OS rates of patients receiving radiotherapy alone and patients receiving radiochemotherapy were 70. 0% and 48.4%, respectively (X2 = 0.01, P = 0. 933 ) ; the five-year DFS rates of patients receiving radiotherapy alone and patients receiving radiochemotherapy were 65. 6% and 48.4%, respectively ( X2 = 0. 09, P = 0. 764 ). The grade 3--4 toxicity rates of radiotherapy alone and radiochemotherapy were 6. 7% and 54. 1%, respectively ( X2 = 41.38, P = 0. 002 ). The radiation dose to the primary lesion and Eastern Cooperative Oncology Group ( ECOG ) score were correlated with OS ( X2 = 3. 1 8, P = 0. 005 ; X2 = 2.97, P = 0. 008 ). Conclusions The clinical effect of radiochemotherapy is similar to that of radiotherapy alone in the patients with stage IEand 11 E nasal and Waldeyer ring NK/T cell lymphoma, but radiochemotherapy has higher toxicity than radiotherapy alone. The radiation dose to the primary lesion and ECOG score are the influential factors for OS.
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2013年第3期180-184,共5页
Chinese Journal of Radiation Oncology
关键词
鼻腔淋巴瘤
放化疗法
韦氏环淋巴瘤
放化疗法
淋巴瘤
NK
T细胞
预后
Nasal cavity lymphoma/radiochemotherapy
Waldeyer ring lymphoma/ radiochemotherapy
Lymphoma, natural killer/T cell
Prognosis